[ad_1]
Representative Abigail Spanberger, D-7th, speaks on the PREPARE Act on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Virginia.
Representative Abigail Spanberger, D-7th, chats with Dr. Frank Gupton, left, after presenting the PREPARE Act on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Va.
Representative Abigail Spanberger, D-7th, arrives to speak on the PREPARE Act on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Virginia.
Representative Abigail Spanberger, D-7th, speaks on the PREPARE Act on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Virginia.
Representative Abigail Spanberger, D-7th, speaks on the PREPARE Act on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Virginia.
Representative Abigail Spanberger, D-7th, center, chats with Brian Anderson, President and CEO of ChamberRVA, third from left, on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Va.
Dr Frank Gupton, second from left, listens with Representative Abigail Spanberger, D-7th, with H. Benson Dendy III, Rector VCU, left, and VCU Provost Fotis Sotiropoulos, second from right, after the introduction of PREPARE Law on Monday, September 27, 2021 at VCU College of Engineering in Richmond, Virginia.
Representative Abigail Spanberger, D-7th, center, chats with Brian Anderson, President and CEO of ChamberRVA, second from left, after presenting the PREPARE Act on Monday, September 27, 2021 at the VCU College of Engineering in Richmond, in Virginia.
Congresswoman Spanberger introduces PREPARE law to VCU
New legislation co-sponsored in Congress by Representative Abigail Spanberger, D-7th, would direct the federal government to create a national strategic reserve of ingredients for essential drugs, a step that could strengthen the development and manufacture of pharmaceuticals in the region of Richmond.
Spanberger was scheduled to introduce a bill titled “PREPARE ACT” on Monday evening to “Promote preparedness and ensure adequate supplies of essential drugs APIs.”
Joined on Monday by academics and local business leaders, Spanberger said legislation is needed to ensure a nationwide supply of essential medicines. Even before the COVID-19 pandemic, shortages occurred for some drugs as many active pharmaceutical ingredients, or APIs, are manufactured outside of the United States.
“Right now, in the United States, we depend on other countries for a range of pharmaceuticals, including many active pharmaceutical ingredients essential to the creation of generic prescription drugs,” Spanberger said at the conference. press release at Virginia Commonwealth University College of Engineering.
About 90% of the drugs prescribed in the United States are generics, but about 87% of the facilities that manufacture the ingredients for these drugs are located outside the United States, Spanberger said.
“Obviously, we really need to re-evaluate our production here at home,†said Spanberger. “As we all know too well, the COVID-19 crisis has demonstrated the vulnerabilities in our supply chain. “
[ad_2]
